Prof. Alireza Heidari
Full Professor and Academic Tenure of
Chemistry &
Director of the BioSpectroscopy Core
Research Laboratory at
Faculty of Chemistry, California South
University (CSU), Irvine, California, USA &
President of American International
Standards Institute (AISI)
Irvine, California, USA.
Emails: Scholar.Researcher.Scientist@gmail.com, Alireza.Heidari@calsu.us
Qualifications
2014, Participate in “Modern Molecular
Electronic–Structure Computations Theory” and also “Nanochemistry” as
postdoctoral research fellow at Faculty of Chemistry, California South
University (CSU), Irvine, California, USA.
2013, Participate in “Project
Management” and also “Oncology, Human Cancer Tissues and Synchrotron Radiation”
as postdoctoral research fellow at School of Chemistry, Faculty of Science,
Monash University, Melbourne, Victoria, Australia.
2012, Ph.D., D.Sc., Biophysical
Chemistry, Faculty of Chemistry, California South University (CSU), Irvine,
California, USA.
2008, M.S., Physical Chemistry, Faculty
of Chemistry, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran.
2005, B.S., Pure Chemistry, Faculty of
Chemistry, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran.
Publications (Selected)
1. A.
Heidari, C. Brown, “Study of Composition and Morphology of Cadmium Oxide (CdO)
Nanoparticles for Eliminating Cancer Cells”, Journal of Nanomedicine Research,
Volume 2, Issue 5, 20 Pages, 2015.
2. A.
Heidari, C. Brown, “Study of Surface Morphological, Phytochemical and
Structural Characteristics of Rhodium (III) Oxide (Rh2O3) Nanoparticles”,
International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Volume
1, Pages 15–19, 2015.
3. A.
Heidari, “Computational Studies on Molecular Structures and Carbonyl and Ketene
Groups’ Effects of Singlet and Triplet Energies of Azidoketene O=C=CH–NNN and
Isocyanatoketene O=C=CH–N=C=O”, J Appl Computat Math 5: e142, 2016.
4. A.
Heidari, “Study of Irradiations to Enhance the Induces the Dissociation of
Hydrogen Bonds between Peptide Chains and Transition from Helix Structure to
Random Coil Structure Using ATR–FTIR, Raman and 1HNMR Spectroscopies”, J Biomol
Res Ther 5: e146, 2016.
5. A.
Heidari, “Future Prospects of Point Fluorescence Spectroscopy, Fluorescence
Imaging and Fluorescence Endoscopy in Photodynamic Therapy (PDT) for Cancer
Cells”, J Bioanal Biomed 8: e135, 2016.
6. A.
Heidari, “Quantitative Structure–Activity Relationship (QSAR) Approximation for
Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as
Anti–Cancer Drugs for the Catalytic Formation of Proviral DNA from Viral RNA
Using Multiple Linear and Non–Linear Correlation Approach”, Ann Clin Lab Res.
4: 1, 2016.
7. A.
Heidari, “Spectroscopy and Quantum Mechanics of the Helium Dimer (He2+), Neon
Dimer (Ne2+), Argon Dimer (Ar2+), Krypton Dimer (Kr2+), Xenon Dimer (Xe2+),
Radon Dimer(Rn2+) and Ununoctium Dimer (Uuo2+) Molecular Cations”, Chem Sci J
7: e112, 2016.
8. A.
Heidari, “A Combined Computational and QM/MM Molecular Dynamics Study on Boron
Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and
Hexagonal Boron Nitride Nanotubes (h–BNNTs) as Hydrogen Storage”, Struct Chem
Crystallogr Commun 2: 1, 2016.
9. A.
Heidari, “Combined Theoretical and Computational Study of the
Belousov–Zhabotinsky Chaotic Reaction and Curtius Rearrangement for Synthesis
of Mechlorethamine, Cisplatin, Streptozotocin, Cyclophosphamide, Melphalan,
Busulphan and BCNU as Anti–Cancer Drugs”, Insights Med Phys. 1: 2, 2016.
10. A.
Heidari, “Ab Initio and Density Functional Theory (DFT) Studies of Dynamic NMR
Shielding Tensors and Vibrational Frequencies of DNA/RNA and Cadmium Oxide
(CdO) Nanoparticles Complexes in Human Cancer Cells”, J Nanomedine
Biotherapeutic Discov 6: e144, 2016.
11. A.
Heidari, “Molecular Dynamics and Monte–Carlo Simulations for Replacement Sugars
in Insulin Resistance, Obesity, LDL Cholesterol, Triglycerides, Metabolic
Syndrome, Type 2 Diabetes and Cardiovascular Disease: A Glycobiological Study”,
J Glycobiol 5: e111, 2016.
12. A.
Heidari, “Nitrogen, Oxygen, Phosphorus and Sulphur Heterocyclic Anti–Cancer
Nano Drugs Separation in the Supercritical Fluid of Ozone (O3) Using
Soave–Redlich–Kwong (SRK) and Pang–Robinson (PR) Equations”, Electronic J Biol
12: 4, 2016.
13. A.
Heidari, “An Analytical and Computational Infrared Spectroscopic Review of
Vibrational Modes in Nucleic Acids”, Austin J Anal Pharm Chem. 3(1): 1058,
2016.
14. A.
Heidari, C. Brown, “Phase, Composition and Morphology Study and Analysis of
Os–Pd/HfC Nanocomposites”, Nano Res Appl. 2: 1, 2016.
15. A.
Heidari, C. Brown, “Vibrational Spectroscopic Study of Intensities and Shifts
of Symmetric Vibration Modes of Ozone Diluted by Cumene”, International Journal
of Advanced Chemistry, 4 (1) 5–9, 2016.
16. A.
Heidari, “Linear and Non–Linear Quantitative Structure–Anti–Cancer–Activity
Relationship (QSACAR) Study of Hydrous Ruthenium (IV) Oxide (RuO2)
Nanoparticles as Non–Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and
Anti–Cancer Nano Drugs”, J Integr Oncol 5: e110, 2016.
17. A.
Heidari, “A Pharmacovigilance Study on Linear and Non–Linear Quantitative
Structure (Chromatographic) Retention Relationships (QSRR) Models for the
Prediction of Retention Time of Anti–Cancer Nano Drugs under Synchrotron
Radiations”, J Pharmacovigil 4: e161, 2016.
18. A.
Heidari, “A Gastrointestinal Study on Linear and Non–Linear Quantitative Structure
(Chromatographic) Retention Relationships (QSRR) Models for Analysis
5–Aminosalicylates Nano Particles as Digestive System Nano Drugs under
Synchrotron Radiations”, J Gastrointest Dig Syst 6: e119, 2016.
19. A.
Heidari, “A Successful Strategy for the Prediction of Solubility
in the Construction of Quantitative Structure–Activity Relationship (QSAR) and
Quantitative Structure–Property Relationship (QSPR) under Synchrotron
Radiations Using Genetic Function Approximation (GFA) Algorithm”, J Mol
Biol Biotechnol 1: 1, 2016.
20. A.
Heidari, “Computational Study on Molecular Structures of C20, C60, C240, C540,
C960, C2160 and C3840 Fullerene Nano Molecules under Synchrotron Radiations
Using Fuzzy Logic”, J Material Sci Eng 5: 282, 2016.
21. A.
Heidari, “Graph Theoretical Analysis of Zigzag Polyhexamethylene Biguanide,
Polyhexamethylene Adipamide, Polyhexamethylene Biguanide Gauze and
Polyhexamethylene Biguanide Hydrochloride (PHMB) Boron Nitride Nanotubes
(BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron
Nitride Nanotubes (h–BNNTs)”, J Appl Computat Math 5: e143, 2016.
22. A.
Heidari, “Yoctosecond Quantitative Structure–Activity Relationship (QSAR) and
Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations
Studies for Prediction of Solubility of Anti–Cancer Nano Drugs in Aqueous
Solutions Using Genetic Function Approximation (GFA) Algorithm”, Insight Pharm
Res. 1: 1, 2016.
23. A. Heidari,
“Polymorphism
in Nano–Sized Graphene Ligand–Induced Transformation of Au38–xAgx/xCux(SPh–tBu)24
to Au36–xAgx/xCux(SPh–tBu)24 (x = 1–12) Nanomolecules for Synthesis of Au144–xAgx/xCux[(SR)60,
(SC4)60, (SC6)60, (SC12)60, (PET)60, (p–MBA)60, (F)60, (Cl)60, (Br)60, (I)60,
(At)60, (Uus)60 and (SC6H13)60] Nano Clusters as Anti–Cancer Nano Drugs”, J
Nanomater Mol Nanotechnol, 6: 3, 2017.
24. A.
Heidari, “Study of Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Olympiadane Nanomolecules as Agent for Cancer Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy under Synchrotorn Radiation”, J Dev Drugs
6: e154.
25. A.
Heidari, “Concurrent Diagnosis of Oncology Influence Outcomes in Emergency
General Surgery for Colorectal Cancer and Multiple Sclerosis (MS)
Treatment Using Magnetic Resonance Imaging (MRI) and Au329(SR)84, Au329–xAgx(SR)84,
Au144(SR)60, Au68(SR)36, Au30(SR)18,
Au102(SPh)44, Au38(SPh)24, Au38(SC2H4Ph)24, Au21S(SAdm)15, Au36(pMBA)24 and Au25(pMBA)18 Nano
Clusters”, J Surgery Emerg Med 1: 21, 2017.
Profile Details
http://calsu.us/index.php/member/prof-dr-alireza-heidari/
Last Updated: 2017-07-16